Olivier Danos

Company: REGENXBIO
Job title: Chief Scientific Officer
Seminars:
Optimizing AAV Vectors for Gene Therapy of Muscle Diseases 11:30 am
Capsids, promoters and payloads Activity in normal and diseased muscle Enhanced Microdystrophins for DMD gene therapyRead more
day: Day Two